Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDRH Looks For Input On Guidance-Development Practices

This article was originally published in The Gray Sheet

Executive Summary

FDA’s device center will seek feedback on its guidance development process and best practices at a June 5 workshop.


Related Content

Industry Proposes Its FDA Guidance Priorities, Reforms
CDRH Sets Performance Goals To Reduce Draft Guidance Ambiguity
Draft Guidance Docs Should Be Transitory, Industry Insists
Is Draft Guidance More Than Meets The Eye? Senators Seek Answers From FDA
Device Makers To FDA: Recall The Recalls Draft Guidance





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts